References in periodicals archive ?
Furthermore, various legal and compliance concerns, such as the Medicaid best price rule, so far have slowed adoption of value-based agreements.
Due to the Swiss best price rule that continues to apply during the six months following the end of the additional acceptance period (December 4, 2014) of the public tender offer, Danaher may not pay more than CHF 17.10 per share for any remaining shares of Nobel Biocare purchased in the open market or otherwise.
Full browser ?